Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2621]

Durvalumab improves OS in PACIFIC trial for unresectable NSCLC after chemoradiotherapy

Durvalumab improves OS in PACIFIC trial for unresectable NSCLC after chemoradiotherapy

Outdoor air pollution exposure significantly higher in women non-smokers with lung cancer than women smokers with lung cancer

Outdoor air pollution exposure significantly higher in women non-smokers with lung cancer than women smokers with...

Promising phase 1/2 results for entrectinib against ROS1 non-small cell lung cancer

Promising phase 1/2 results for entrectinib against ROS1 non-small cell lung cancer

Smoking cessation services widely accepted during lung cancer screenings

Smoking cessation services widely accepted during lung cancer screenings

Atezolizumab combination improves PFS for advanced NSCLC patients

Atezolizumab combination improves PFS for advanced NSCLC patients

Study shows women with non-small cell lung cancers live longer than men

Study shows women with non-small cell lung cancers live longer than men

Survey data from Lung Cancer Alliance highlights the unmet emotional needs of long-term lung cancer survivors

Survey data from Lung Cancer Alliance highlights the unmet emotional needs of long-term lung cancer survivors

Comprehensive genomic profiling aids in the identification of personalised therapeutic options

Comprehensive genomic profiling aids in the identification of personalised therapeutic options

CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated with crizotinib

CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated...

Researchers look to immune cell shapes to predict how well the body will fight lung cancers

Researchers look to immune cell shapes to predict how well the body will fight lung cancers

More from ecancer